RSS
Ionis Pharmaceuticals
Tegsedi receives European marketing authorisation approval
Akcea Therapeutics and Ionis Pharmaceuticals have announced that Tegsedi (inotersen) has received European marketing authorisation approval for the treatment of stage 1 or stage 2 polyneuropathy in adult patients with hATTR more
Drug lowers harmful Huntington’s disease proteins in humans, according to research
Researchers from the UCL Huntington’s Disease Centre have developed a drug that has been shown to be safe and well-tolerated in its first human trial, successfully lowering the level of harmful huntingtin protein in the nervous system more
Merck and Ionis Pharma awarded $200m in patent infringement battle
Gilead Sciences is to pay $200m for infringing upon Merck and Ionis Pharmaceuticals’ Hepatitis C drug patents more
